Announced

HOPE Therapeutics and NRx Pharmaceuticals to acquire a minority stake in Cohen and Associates.

Synopsis

HOPE Therapeutics, a clinical care delivery organization, and NRx Pharmaceuticals, biopharmaceutical company, agreed to acquire a minority stake in Cohen and Associates, a Psychiatry clinic. Financial terms were not disclosed. "We are delighted to welcome Rebecca and her team to the HOPE family. Her extensive experience with neuroplastic therapies, combined with compassionate patient care exemplify our culture of bringing HOPE to life," Jonathan Javitt and Matthew Duffy, HOPE Therapeutics Co-CEOs.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - HOPE Therapeutics and NRx Pharmaceuticals to acquire a minority stake in Cohen and Associates.